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Propositions
Cellular Modifications and Interventions 
for the Damaged Heart
1. Insulin-like growth factors promote Brachyury+ early mesodermal proliferation 
in vitro through selective phosphorylation of a downstream Akt pathway. 
Treatment with insulin-like growth factors steers embryonic stem cell 
differentiation towards an Nkx2.5+ cardiac progenitor cell-fate. (this thesis)
2. In an in vitro cardiac fibrosis model, forced cellular fusion of neonatal rat 
ventricular myocytes with human ventricular scar cells markedly decreases 
arrhythmogenicity through several mechanisms, including improved 
coupling, improved excitability and increased repolarization force. (this thesis)
3. Down-regulation of connexin 43 leads to conduction slowing and formation 
of phase islands of spatially discordant action potential duration alternans. 
Presence of adjacent alternans phase islands of opposite phase creates a 
vulnerable substrate for wavebreak formation and re-entry initiation. (this 
thesis)
4. Optogenetic engineering of atrial cardiomyocytes can terminate re-entry by 
brief light pulses. (this thesis)
5. The combination of three transcription factors, Gata4, Mef2c, and Tbx5, can 
rapidly and efficiently induce cardiomyocyte-like cells from postnatal cardiac 
and dermal fibroblasts. iCMs were similar to neonatal cardiomyocytes in 
global gene expression profile, electrophysiologically, and could contract 
spontaneously, demonstrating that functional cardiomyocytes can be 
generated from differentiated somatic cells by defined factors. (Ieda M., et. al. 
Cell. 2010;142:375-386)
6. Minimally invasive TBX18 gene transfer creates physiologically relevant 
pacemaker activity in complete heart block, providing evidence for therapeutic 
somatic reprogramming in a clinically relevant disease model. (Hu Y.F., et. al. Sci 
Transl Med. 2014;6:245)
7. Our study also provides reassurance about the arrhythmogenic risk of cardiac 
repair with immature stem cell-derived cardiomyocytes. We observed an 
arrhythmia-suppressive effect that was unique to cardiomyocyte grafts and 
occurred despite incomplete host-graft coupling. (Shiba Y., et. al. Nature. 
2012;489:322-325)
8. Human embryonic stem-cell derived cardiomyocytes can remuscularize 
substantial amounts of the infarcted monkey heart. Comparable 
remuscularization of a human heart should be possible, but potential 
arrhythmic complications need to be overcome. (Chong J.J., et. al. Nature. 
2014;510:273-277)
9. Curious that we spend more time congratulating people who have succeeded 
than encouraging people who have not. (Neil deGrasse Tyson, Twitter January 
23, 2012)
10. Your time is limited, so don’t waste it living someone else’s life. Don’t be 
trapped by dogma – which is living with the results of other people’s thinking. 
Don’t let the noise of others’ opinions drown out your inner voice. And most 
important, have the courage to follow your heart and intuition. (Steve Jobs, 
Stanford Commencement address June 12, 2005)
11. We look for medicine to be an orderly field of knowledge and procedure. 
But it is not. It is an imperfect science, an enterprise of constantly changing 
knowledge, uncertain information, fallible individuals, and at the same time 
lives on the line. There is science in what we do, yes, but also habit, intuition, 
and sometimes plain old guessing. The gap between what we know and 
what we aim for persists. And this gap complicates everything we do. (Atul 
Gawande, Complications: a surgeon’s notes on an imperfect science)
12. At the end of a PhD training, you should not forget to stop w(o/a)ndering.
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